# rs56007086 and Breast cancer (16q12)

Configuration `single`, named mode, seed 0. Models: generator deepseek/deepseek-v4.1-flash-1017, critic deepseek/deepseek-v4.1-flash-1017, summariser deepseek/deepseek-v4.1-flash-1017. Cost $0.00 over 1 model calls; 15 s.

Variant `chr16:52565398:G>A` (germline); expression context: DepMap:ACH-000019 (MCF7).

## Ranked chains

### 1. null: Null: no TF-mediated effect of rs56007086; linked causal variant or no allelic effect (p = 0.50)

Null chain: no TF-mediated effect of this variant.

Predictions: No allele-specific TF binding at rs56007086; No reproducible ref/alt enhancer reporter difference in MCF7; Any TOX3/16q12 expression association is due to a linked causal variant or is not allele-specific at this position

Falsified if: Allele-specific FOXA1 binding is reproducibly ref>alt in MCF7 nuclear extract and is abolished by FOXA1 knockdown or anti-FOXA1 supershift.; Ref/alt enhancer reporter activity differs in MCF7 in a FOXA1-dependent manner.; The locus shows an allele-specific chromatin/expression effect that tracks with the variant rather than a linked variant.

### 2. foxa1: FOXA1 binds the ref allele at a 16q12 enhancer and modulates TOX3 (p = 0.25)

TF FOXA1 (stated coverage not_checked; registry own_model), ref allele binds more; element 16q12.1 breast-cancer-risk enhancer near TOX3/CASC16; gene TOX3; cell type MCF7 breast luminal epithelial cells.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | FOXA1 binds the ref G allele more strongly than the alt A allele at rs56007086. | missing | none |
| element | rs56007086 lies in a 16q12.1 enhancer element near TOX3/CASC16 whose activity can be modulated by FOXA1. | missing | none |
| gene | This enhancer regulates TOX3 expression in breast cells. | missing | none |
| cell_type | The relevant cell type is MCF7 breast luminal epithelial cells, where FOXA1 is expressed and active. | missing | none |
| phenotype | Altered FOXA1-dependent enhancer activity changes TOX3 expression and thereby influences 16q12 breast cancer risk; the net direction is not assumed because FOXA1 can repress. | missing | none |

Predictions: Allele-specific FOXA1 binding: ref>alt; FOXA1 knockdown reduces allele-specific enhancer/reporter effect; FOXA1 ChIP enrichment at the locus is allele-biased toward ref; Effect should be FOXA1-dependent and detectable in MCF7

Falsified if: Ref and alt probes show equal FOXA1 binding in EMSA or allele-specific ChIP; FOXA1 knockdown does not change ref/alt reporter activity in MCF7; Allele-specific enhancer activity is not present at rs56007086

### 3. esr1: ESR1/ER binds the ref allele at an estrogen-responsive 16q12 enhancer (p = 0.15)

TF ESR1 (stated coverage not_checked; registry own_model), ref allele binds more; element 16q12.1 enhancer near TOX3/CASC16; gene TOX3; cell type MCF7 breast luminal epithelial cells.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | ESR1/ER binds the ref G allele more strongly than the alt A allele at rs56007086. | missing | none |
| element | rs56007086 lies in an estrogen-responsive 16q12.1 enhancer near TOX3/CASC16. | missing | none |
| gene | This estrogen-responsive enhancer regulates TOX3 expression. | missing | none |
| cell_type | The relevant context is MCF7 breast luminal epithelial cells with estrogen-receptor signaling. | missing | none |
| phenotype | Altered ESR1-dependent enhancer activity changes TOX3 expression and influences breast cancer risk in an estrogen-dependent manner. | missing | none |

Predictions: Allele-specific ESR1/ER binding: ref>alt; Effect is enhanced by estrogen and reduced by ESR1 knockdown; FOXA1 knockdown should not fully abolish the ESR1-dependent allele effect; ERE mutation should reduce reporter effect

Falsified if: Allele-specific ESR1/ER binding is not seen after estrogen treatment; ESR1 knockdown or ERE mutation does not affect ref/alt reporter activity; FOXA1, not ESR1, accounts for the allele-specific binding

### 4. cebpb: CEBPB binds the ref allele at a 16q12 enhancer (p = 0.10)

TF CEBPB (stated coverage not_checked; registry own_model), ref allele binds more; element 16q12.1 enhancer near TOX3/CASC16; gene TOX3; cell type MCF7 breast luminal epithelial cells.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | CEBPB binds the ref G allele more strongly than the alt A allele at rs56007086. | missing | none |
| element | rs56007086 lies in a 16q12.1 enhancer near TOX3/CASC16 with a CEBPB-responsive element. | missing | none |
| gene | This enhancer regulates TOX3 expression. | missing | none |
| cell_type | The relevant cell type is MCF7 breast luminal epithelial cells, where CEBPB can contribute to enhancer activity. | missing | none |
| phenotype | Altered CEBPB-dependent enhancer activity changes TOX3 expression and influences breast cancer risk. | missing | none |

Predictions: Allele-specific CEBPB binding: ref>alt; CEBPB knockdown reduces ref/alt reporter difference; CEBPB ChIP enrichment at the locus is allele-biased toward ref; Effect is independent of FOXA1 and ESR1

Falsified if: Allele-specific CEBPB binding is absent in MCF7 nuclear extract; CEBPB knockdown does not affect ref/alt reporter activity; The allele effect is explained by FOXA1 or ESR1

## Prediction matrix

| Test | Cost | Separates top two | null | foxa1 | esr1 | cebpb |
| --- | --- | --- | --- | --- | --- | --- |
| Allele-specific FOXA1 EMSA with MCF7 nuclear extract plus anti-FOXA1 supershift | high | yes | No allele-specific FOXA1 binding or supershift | Ref>alt FOXA1 binding and anti-FOXA1 supershift |  |  |
| Allele-specific EMSA with anti-ESR1 and anti-CEBPB supershifts | low | no |  |  | Estrogen-dependent ESR1/ER allele-specific binding | CEBPB allele-specific binding |

## Next experiment

Allele-specific EMSA/supershift at rs56007086 using MCF7 nuclear extract and anti-FOXA1 antibody, comparing ref G and alt A probes; this is the cheapest direct test separating the top FOXA1 chain from the null. A positive ref>alt FOXA1 supershift supports the FOXA1 chain; absence supports the null or shifts weight to another TF chain.

## Flags

- none

## Evidence
